미국 약사

08/29/2026

https://www.msn.com/en-us/money/companies/success-after-a-century-of-failures-inside-moderna-and-merck-s-cancer-vaccine-breakthrough/ar-AA2b9T86

08/29/2026

https://www.msn.com/en-us/health/general/us-fda-approves-takeda-protagonist-s-drug-for-rare-blood-cancer/ar-AA2b8W8Y

08/29/2026

US FDA approves Lilly's Mounjaro to reduce cardiovascular risk

08/28/2026

https://www.cnbc.com/2026/08/28/biocryst-is-profitable-now-it-wants-to-buy-more-rare-disease-drugs.html

08/28/2026

https://www.reuters.com/business/healthcare-pharmaceuticals/china-approves-jjs-oral-psoriasis-pill-says-drugmaker-2026-08-27/

China's drug regulator ‌has approved Johnson & Johnson's oral pill for psoriasis, the company said on Thursday, intensifying competition in the ​world's second-largest pharmaceutical market with rivals ​including Bristol Myers Squibb and AbbVie .

08/28/2026

https://www.msn.com/en-us/news/other/us-fda-approves-roivant-priovants-skin-and-muscle-disease-drug/ar-AA2b4YgG

08/28/2026

https://www.reuters.com/business/healthcare-pharmaceuticals/beyond-scale-men-turn-cosmetic-clinics-complete-weight-loss-transformation-2026-08-28/

As top-selling weight-loss drugs help more U.S. men slim down, a growing number are seeking cosmetic treatments for sagging skin, hair loss and dental issues to complete their physical transformation, patients and plastic surgeons say.

08/28/2026

https://www.msn.com/en-us/news/other/cytokinetics-eyes-expanded-use-of-heart-drug-after-promising-late-stage-data/ar-AA2b6xQy

By Bhanvi Satija and Mariam Sunny Aug 28 (Reuters) - Cytokinetics said on Friday detailed late-stage data showed its drug, aficamten, significantly improved symptoms and exercise capacity in patients with a genetic heart condition that currently has no approved treatments. The results, presented at....

08/27/2026

https://www.reuters.com/legal/litigation/huawei-plans-more-ai-pharma-tie-ups-says-healthcare-president-2026-08-27/

08/27/2026

https://www.reuters.com/business/healthcare-pharmaceuticals/astrazenecas-asthma-drug-tezspire-meets-all-goals-late-stage-esophagitis-trial-2026-08-27/

AstraZeneca said on Thursday its asthma drug Tezspire met ‌the main goals of a late-stage trial in patients with a chronic inflammatory disorder of the oesophagus, offering a boost after a string of pipeline setbacks.